(19)
(11) EP 1 206 564 A1

(12)

(43) Date of publication:
22.05.2002 Bulletin 2002/21

(21) Application number: 00955263.9

(22) Date of filing: 28.07.2000
(51) International Patent Classification (IPC)7C12P 19/30
(86) International application number:
PCT/US0020/565
(87) International publication number:
WO 0109/367 (08.02.2001 Gazette 2001/06)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 28.07.1999 US 146003 P

(71) Applicant: Genome Therapeutics Corporation
Waltham, MA 02453-8443 (US)

(72) Inventors:
  • THOMANN, Hans-Ulrich
    Lexington, MA 02421 (US)
  • LEIGHTON, Jeff
    Brookline, MA 02445 (US)
  • SMITH, Douglas
    Gloucester, MA (US)
  • KELLY, Christopher, T.
    Waltham, MA (US)

(74) Representative: Duckworth, Timothy John 
J.A. Kemp & Co.,14 South Square,Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) METHOD OF DESIGNING DRUGS THROUGH REVERSE POLYMORPHISM OF TARGET GENES